Compared with normal controls, AD model rats (AD-CON) exhibited significantly increased hippocampal Aβ deposition, impaired insulin signaling pathway (as evidenced by reduced Akt and GSK-3β phosphorylation levels), increased neuroinflammation, elevated acetylcholinesterase activity, and memory dysfunction. The gene discussed is AKT1; the disease is Alzheimer disease.